• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Bayer AG

Bayer AG

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Regeneron and Sanofi Announce Praluent™ (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA

    Regeneron and Sanofi Announce Praluentâ„¢ (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA

  2. Isis Pharmaceuticals Appoints Sarah Boyce As Chief Business Officer

    Isis Pharmaceuticals Appoints Sarah Boyce As Chief Business Officer

  3. Research and Markets: Bayer /Onyx's Stivarga Colorectal Cancer Treatment - Forecast and Market Analysis to 2023

    Research and Markets: Bayer /Onyx's Stivarga Colorectal Cancer Treatment - Forecast and Market Analysis to 2023

  4. Research and Markets: Polyurea Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Scenario And Forecasts, 2012 To 2020

    Research and Markets: Polyurea Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Scenario And Forecasts, 2012 To 2020

  5. Regeneron and Sanofi Announce Positive Topline Results from First Phase 3 Trials Evaluating Monthly Dosing of Alirocumab in Patients with Hypercholesterolemia

    Regeneron and Sanofi Announce Positive Topline Results from First Phase 3 Trials Evaluating Monthly Dosing of Alirocumab in Patients with Hypercholesterolemia

  6. Regeneron and Sanofi Announce Praluent™ (alirocumab) Marketing Authorization Application has Been Accepted for Review by EMA

    Regeneron and Sanofi Announce Praluentâ„¢ (alirocumab) Marketing Authorization Application has Been Accepted for Review by EMA

  7. Research and Markets: Global Leather Chemicals Market 2014-2019: BASF, TFL Ledertechnik Gmbh, Stahl International, Lanxess, Bayer & Clariant International Dominate the $7.9 Billion Industry

    Research and Markets: Global Leather Chemicals Market 2014-2019: BASF, TFL Ledertechnik Gmbh, Stahl International, Lanxess, Bayer & Clariant International Dominate the $7.9 Billion Industry

  8. ImmunoGen, Inc. Announces 2015 Outlook for Product Pipeline

    ImmunoGen, Inc. Announces 2015 Outlook for Product Pipeline

  9. Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA

    Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA

  10. Conkwest Appoints Robert Rosen and Henry Ji to its Board of Directors

    Conkwest Appoints Robert Rosen and Henry Ji to its Board of Directors

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.